IMDX - Insight Molecular Diagnostics Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 5.77 0.27 (4.59%) | --- | 0.0 (0.0%) | -0.05 (-0.9%) | 0.0 (0.0%) | -0.02 (-0.41%) | --- | 0.0 (0.0%) |
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.
Category:
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.3
- Diluted EPS:
- -0.3
- Basic P/E:
- -20.1167
- Diluted P/E:
- -20.1167
- RSI(14) 1m:
- 45.54
- VWAP:
- 6.04
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|